UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Long-term Cognitive Outcomes in Patients With Pediatric-Onset vs Adult-Onset Multiple Sclerosis

JAMA neurology, 2019-09, Vol.76 (9), p.1028

2019

Volltextzugriff (PDF)

Health-related quality of life in multiple sclerosis: Direct and indirect effects of comorbidity

Neurology, 2016-04, Vol.86 (15), p.1417-1424

2016

Volltextzugriff (PDF)

Comorbidity increases the risk of relapse in multiple sclerosis: A prospective study

Neurology, 2017-12, Vol.89 (24), p.2455-2461

2017

Volltextzugriff (PDF)

Incidence and prevalence of multiple sclerosis in Europe: a systematic review

BMC neurology, 2013-09, Vol.13 (1), p.128-128, Article 128

2013

Volltextzugriff (PDF)

Etiology, effects and management of comorbidities in multiple sclerosis: recent advances

Frontiers in immunology, 2023, Vol.14, p.1197195-1197195

2023

Volltextzugriff (PDF)

Determinants of non-adherence to disease-modifying therapies in multiple sclerosis: A cross-Canada prospective study

Multiple sclerosis, 2017-04, Vol.23 (4), p.588-596

2017

Volltextzugriff (PDF)

Assessment of differential item functioning of the PHQ-9, HADS-D and PROMIS-depression scales in persons with and without multiple sclerosis

Journal of psychosomatic research, 2023-09, Vol.172, p.111415-111415, Article 111415

2023

Volltextzugriff (PDF)

Variations in case definition affect prevalence but not outcomes of mild cognitive impairment

Neurology, 2003-11, Vol.61 (9), p.1179-1184

2003

Volltextzugriff (PDF)

P.014 A Novel Canadian Family with the Rare IVS10+14 Tau Mutation

Canadian journal of neurological sciences, 2021-11, Vol.48 (s3), p.S23-S24

2021

Volltextzugriff (PDF)

P.005 A virtual interdisciplinary diagnostic memory clinic: rural patient and caregiver satisfaction

Canadian journal of neurological sciences, 2023-06, Vol.50 (s2), p.S58-S58

2023

Volltextzugriff (PDF)

Adverse health behaviours are associated with depression and anxiety in multiple sclerosis: A prospective multisite study

Multiple sclerosis, 2016-04, Vol.22 (5), p.685-693

2016

Volltextzugriff (PDF)

Expression of the inhibitor of apoptosis protein family in multiple sclerosis reveals a potential immunomodulatory role during autoimmune mediated demyelination

Multiple sclerosis, 2008-06, Vol.14 (5), p.577-594

2008

Volltextzugriff (PDF)

Sex differences evident in elevated anxiety symptoms in multiple sclerosis, inflammatory bowel disease, and rheumatoid arthritis

Frontiers in psychiatry, 2023, Vol.14, p.1260420-1260420

2023

Volltextzugriff (PDF)

A comparison of health utility measures for the evaluation of multiple sclerosis treatments

Journal of neurology, neurosurgery and psychiatry, 2005-01, Vol.76 (1), p.58-63

2005

Volltextzugriff (PDF)

Outcomes of incident mild cognitive impairment in relation to case definition

Journal of neurology, neurosurgery and psychiatry, 2005-08, Vol.76 (8), p.1175-1177

2005

Volltextzugriff (PDF)

Comorbidity is associated with pain-related activity limitations in multiple sclerosis

Multiple sclerosis and related disorders, 2015-09, Vol.4 (5), p.470-476

2015

Volltextzugriff (PDF)

Neuropsychological predictors of incident dementia in patients with vascular cognitive impairment, without dementia

Stroke (1970), 2002-08, Vol.33 (8), p.1999-2002

2002

Volltextzugriff (PDF)

Disease-Modifying Therapies and Adherence in Multiple Sclerosis: Comparing Patient Self-Report with Pharmacy Records

Neuroepidemiology, 2017-01, Vol.48 (3-4), p.124-130

2017

Volltextzugriff (PDF)

Polygenic liability for anxiety in association with comorbid anxiety in multiple sclerosis

Annals of clinical and translational neurology, 2024-06, Vol.11 (6), p.1393-1404

2024

Volltextzugriff (PDF)

Minimal Neuropsychological Assessment of MS Patients: A Consensus Approach

Clinical neuropsychologist, 2002-08, Vol.16 (3), p.381-397

2002

Volltextzugriff (PDF)

Neuropsychiatric syndromes in patients with systemic lupus erythematosus and rheumatoid arthritis

Journal of rheumatology, 2005-08, Vol.32 (8), p.1459

2005

Volltextzugriff (PDF)

Social anxiety in a multiple sclerosis clinic population

Multiple sclerosis, 2009-03, Vol.15 (3), p.393-398

2009

Volltextzugriff (PDF)

Fatigue and Comorbidities in Multiple Sclerosis

International journal of MS care, 2016-03, Vol.18 (2), p.96-104

2016

Volltextzugriff (PDF)

Construction and Validation of a Fatigue Impact Scale for Daily Administration (D-FIS)

Quality of life research, 2002-05, Vol.11 (3), p.263-272

2002

Volltextzugriff (PDF)

Disease progression among multiple sclerosis patients before and during a disease-modifying drug program: a longitudinal population-based evaluation

Multiple sclerosis, 2009-11, Vol.15 (11), p.1286-1294

2009

Volltextzugriff (PDF)

1 – 25 von 312

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(237)
Mit Volltextzugriff
(287)

Publikationsform

Artikel
(310)
Tagungsberichte
(2)

Sprache

Englisch
(311)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(287)
Physical Sciences
(212)
Physics
(203)
Physics, Condensed Matter
(127)
Exact Sciences And Technology
(101)
Materials Science
(95)
Condensed Matter: Electronic Structure, Electrical, Magnetic, And Optical Properties
(82)
Technology
(79)
Physics, Applied
(78)
Materials Science, Multidisciplinary
(74)
Life Sciences & Biomedicine
(71)
Humans
(58)
Female
(44)
Male
(40)
Biological And Medical Sciences
(37)
Neurosciences & Neurology
(34)
Applied Sciences
(33)
Adult
(32)
Clinical Neurology
(31)
Magnetic Properties And Materials
(31)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Long-term Cognitive Outcomes in Patients With Pediatric-Onset vs Adult-Onset Multiple Sclerosis

Health-related quality of life in multiple sclerosis: Direct and indirect effects of comorbidity

Comorbidity increases the risk of relapse in multiple sclerosis: A prospective study

Incidence and prevalence of multiple sclerosis in Europe: a systematic review

Etiology, effects and management of comorbidities in multiple sclerosis: recent advances

Determinants of non-adherence to disease-modifying therapies in multiple sclerosis: A cross-Canada prospective study

Assessment of differential item functioning of the PHQ-9, HADS-D and PROMIS-depression scales in persons with and without multiple sclerosis

Variations in case definition affect prevalence but not outcomes of mild cognitive impairment

P.014 A Novel Canadian Family with the Rare IVS10+14 Tau Mutation

P.005 A virtual interdisciplinary diagnostic memory clinic: rural patient and caregiver satisfaction

Adverse health behaviours are associated with depression and anxiety in multiple sclerosis: A prospective multisite study

Expression of the inhibitor of apoptosis protein family in multiple sclerosis reveals a potential immunomodulatory role during autoimmune mediated demyelination

Sex differences evident in elevated anxiety symptoms in multiple sclerosis, inflammatory bowel disease, and rheumatoid arthritis

A comparison of health utility measures for the evaluation of multiple sclerosis treatments

Outcomes of incident mild cognitive impairment in relation to case definition

Comorbidity is associated with pain-related activity limitations in multiple sclerosis

Neuropsychological predictors of incident dementia in patients with vascular cognitive impairment, without dementia

Disease-Modifying Therapies and Adherence in Multiple Sclerosis: Comparing Patient Self-Report with Pharmacy Records

Polygenic liability for anxiety in association with comorbid anxiety in multiple sclerosis

Minimal Neuropsychological Assessment of MS Patients: A Consensus Approach

Neuropsychiatric syndromes in patients with systemic lupus erythematosus and rheumatoid arthritis

Social anxiety in a multiple sclerosis clinic population

Fatigue and Comorbidities in Multiple Sclerosis

Construction and Validation of a Fatigue Impact Scale for Daily Administration (D-FIS)

Disease progression among multiple sclerosis patients before and during a disease-modifying drug program: a longitudinal population-based evaluation

Suchergebnisse filtern